Brandinium

Trademark search for:

PRIMA BIOMED

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results
Also check across: EU CA AU NZ CH

USPTO Filing History

Key events recorded for this trademark application

  • 2016-05-06 — Application filed
  • 2016-09-01 — Sn assigned for sect 66a appl from ib
  • 2016-09-03 — Application filed
  • 2016-09-03 — Assigned to examiner
  • 2016-09-07 — Application filed
  • 2016-09-10 — Final disposition recorded
  • 2016-09-11 — Office action issued
  • 2016-09-16 — Office action issued
  • 2016-09-16 — Office action issued
  • 2016-10-13 — Office action issued
  • 2016-12-16 — New representative at ib received
  • 2017-02-10 — New representative at ib received
  • 2017-03-16 — Teas change of correspondence received
  • 2017-03-16 — Office action issued
  • 2017-03-30 — Assigned to lie
  • 2017-04-04 — Data modification completed
  • 2017-04-04 — Teas/email correspondence entered
  • 2017-04-04 — Correspondence received in law office
  • 2017-04-06 — Teas voluntary amendment received
  • 2017-04-19 — Approved for pub - principal register
  • 2017-04-19 — Teas/email correspondence entered
  • 2017-04-19 — Correspondence received in law office
  • 2017-04-26 — Law office publication review completed
  • 2017-05-10 — Notification of notice of publication e-mailed
  • 2017-05-18 — New representative at ib received
  • 2017-05-30 — Published for opposition
  • 2017-05-30 — Official gazette publication confirmation e-mailed
  • 2017-07-28 — New representative at ib received
  • 2017-08-15 — Registered-principal register
  • 2017-08-17 — Limitation of goods received from ib
  • 2017-08-23 — Limitation from the ib examined and entered
  • 2017-08-30 — Correction under section 7 - processed
  • 2017-11-15 — Final disposition recorded
  • 2017-11-24 — Limitation of goods received from ib
  • 2017-12-05 — Case assigned to post registration paralegal
  • 2017-12-05 — Correction under section 7 - processed
  • 2017-12-05 — Limitation from the ib examined and entered
  • 2017-12-05 — Final disposition recorded
  • 2017-12-05 — Final disposition recorded
  • 2017-12-22 — Final disposition recorded
  • 2018-02-02 — Change of name/address rec'd from ib
  • 2018-08-05 — Partial invalidation of reg ext protection created
  • 2018-08-27 — Invalidation reviewed - no action required by office
  • 2022-08-15 — Courtesy reminder - sec. 71 (6-yr) e-mailed
  • 2022-10-12 — Attorney/dom.rep.revoked and/or appointed
  • 2022-10-12 — Teas change of owner address received
  • 2022-10-12 — Teas change of correspondence received
  • 2022-10-12 — Applicant/correspondence changes (non-responsive) entered
  • 2022-10-12 — Teas revoke/app/change addr of atty/dom rep received
  • 2024-03-01 — Cancelled section 71
  • 2024-03-01 — Final status recorded
  • 2024-11-02 — Total invalidation of reg ext protection created
  • 2024-11-29 — Invalidation processed
  • 2024-11-30 — Total invalidation of reg ext protection sent to ib
  • 2024-12-21 — Total invalidation processed by the ib

Owner Information

Immutep Limited
AU
Prima Biomed Ltd
AU
Prima Biomed Ltd
AU

Correspondent

Edward Playfair Adams and Reese LLP
1600 West End Avenue
Suite 1400
Nashville, TN 37203

Filing Details

Filing Date:
2016-05-06
Status Date:
2024-03-01
Category:
Pharmaceuticals
Filing Year:
2016

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.